At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CELZ Creative Medical Technology Holdings, Inc.
Market Closed 04-26 16:00:00 EDT
4.32
-0.08
-1.82%
盘后4.32
+0.000.00%
16:00 EDT
High4.42
Low4.30
Vol11.16K
Open4.32
D1 Closing4.40
Amplitude2.77%
Mkt Cap5.86M
Tradable Cap5.70M
Total Shares1.36M
T/O48.62K
T/O Rate0.85%
Tradable Shares1.32M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BRIEF-Creative Medical Technology Provides Corporate Update
Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.